Literature Cited

  • 1
    CDC: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41 (RR 17): 135, 1992.
  • 2
    CDC: Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR 41(RR 8): 117, 1992.
  • 3
    National Committee for Clinical Laboratory Standards: Clinical applications of flow cytometry. Quality assurance and immunophenotyping of peripheral blood lymphocytes. NCCLS Publication H24-T, Villanova, PA, 1992.
  • 4
    Calvelli T, Denny TN, Paxton H, Gelman R, Kagan J: Guidelines flow cytometric immunophenotyping: A report from the National Institutes of Allergy and Infectious Diseases, Division of AIDS. Cytometry 677: 702715, 1993.
  • 5
    Association of State and Territorial Public Health Laboratory Directors: Report and recommendations. Markers of disease progression. Eighth Annual Conference on Human Retrovirus Testing, Atlanta, GA, 1993, pp 69.
  • 6
    Nicholson JKA, Browning SW, Orloff SL, McDougal JS: Inactivation of HIV-infected H9 cells in whole blood preparations by lysing/fixing reagents used in flow cytometry. J Immunol Methods 160: 215218, 1993.
  • 7
    Nicholson JKA, Green TA: Selection of anticoagulants for lymphocyte immunophenotyping: effect of specimen age on results. J Immunol Methods 165: 3135, 1993.
  • 8
    Paxton H, Bendele T: Effect of time, temperature, and anticoagulant on flow cytometry and hematological values. Ann NY Acad Sci 677: 440443, 1993.
  • 9
    Margolick JB, Scott ER, Odaka N, Saah AJ: Flow cytometric analysis of gamma delta T cells and natural killer cells in HIV-1 infection. Clin Immunol Immunopathol 58: 126138, 1991.